The Board of Directors hereby convenes Lifesciencelaw.dk members to the Annual General Meeting 2026 on Wednesday 13th of May 2026 from 16.00-17.00 CET. The annual general meeting is held physically at Novo Nordisk, Novo Allé 1 (Building: NN1), 2880 Bagsværd. It will be possible to participate virtually. Each member has one vote at the annual general meeting and voting can only be done by attending the meeting either physically or virtually. Voting by proxy is not accepted.
Participation in the annual general meeting is subject to the prior registration by email to Uffe Mark Hansen (uffe_mark.hansen@novartis.com) or Sebastian Rønnow (ZSRW@novonordisk.com) no later than 10th of May 2026 at noon. Those registered will receive an MS Teams invitation.
Agenda
- Election of the chair of the meeting and secretary
- The chairperson’s report on Lifesciencelaw.dk’s past activities since last ordinary general assembly
- Presentation of the annual accounts for approval
- Presentation of the Board of Director’s plan for future activities and the treasurer’s corresponding budget for approval
- Proposal for the next term (2026/2027) membership fee for approval
- Election of board members and alternates
- Appointment of auditors
- Any other business
The Board of Directors,
Copenhagen, 1st of May 2026